Corium to Participate in BioPharma Dealmakers Webcast on New Innovations in Drug Delivery Technology
Mar 22, 2017 - GlobeNewswire
MENLO PARK, Calif., March 22, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Joseph J. Sarret, M.D., Chief Business Officer, will participate in a BioPharma Dealmakers webcast featuring five companies innovating drug delivery technology. The webcast, part of the BioPharma Dealmakers series of The Nature Publishing...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
